Skip to main content
CTRE
NYSE Real Estate & Construction

CareTrust Q3 Normalized FFO Up 20%, Raises 2026 Guidance Midpoints

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: REIT Stocks · Real Estate
Sentiment info
Positive
Importance info
7
Price
$37.18
Mkt Cap
$8.785B
52W Low
$34.55
52W High
$43.62
52W Position info
7.6% above low
Off High info
15% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

CTRE is trading near its 52-week low of $34.55 (7.6% above the low).

Summary

CareTrust reported Q3 Normalized FFO of $129.2 million ($0.54 per share, up 20% year over year) and raised 2026 guidance to $2.08-$2.09 Normalized FFO per share, with leverage at just 1.4x ahead of a $1.2 billion acquisition pipeline.


Key Events · Earnings and Guidance · CTRE

  • Q3 Normalized FFO Up 20%

    Normalized FFO was $129.2 million, or $0.54 per diluted share, versus $0.45 a year earlier; net income was $83.7 million ($0.35 per share) on revenue of $176.4 million, up from $132.4 million.

  • 2026 Guidance Raised

    Management lifted the low end of full-year guidance to $2.08-$2.09 Normalized FFO per share and $2.04-$2.05 Normalized FAD per share, with net income of $1.50-$1.51 per share on a 240 million diluted share count.

  • Leverage Well Below Target

    Net debt to annualized normalized run rate EBITDA was 1.4x at quarter end, against a 4.0x-5.0x target range, with $1.6 billion available on the $2.0 billion revolver and $100 million of cash as of November 4, 2026.

  • Equity Already Issued in 2026

    The quarter included $578.2 million of gross proceeds from settling the May 2026 forward equity offering and $280.5 million from ATM issuances; $599 million remains available under the ATM program.


Analysis · CTRE · Real Estate & Construction

The quarter was already out via the 10-Q and press coverage, but this 8-K carries the piece investors trade on: management raised the low end of 2026 guidance, now $2.08-$2.09 Normalized FFO per share and $2.04-$2.05 Normalized FAD per share. Against a $2.9 billion year-to-date investment pace at an 8.1% blended yield, leverage at 1.4x net debt to annualized run-rate EBITDA sits far below the 4.0x-5.0x target, leaving room to fund the remaining LNT homes and a $1.2 billion pipeline without new equity. The offset is dilution already taken: roughly 20.0 million ATM shares sold in 2026 at a $38.69 average plus a 14.4 million-share forward settlement, which is why per-share growth trails the absolute FFO increase.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 35.2% of the 2649 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CTRE was trading at $37.18 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $8.8B. The 52-week trading range was $34.55 to $43.62. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CTRE - Latest Insights

CTRE
Nov 05, 2026, 4:12 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $37.18
Real-time Price: $37.27 info
Change: +$0.0875 (+0.24%) info
Market Cap: $8.785B info
CTRE
Nov 05, 2026, 4:07 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $37.18
Real-time Price: $37.27 info
Change: +$0.0875 (+0.24%) info
Market Cap: $8.785B info
CTRE
Oct 29, 2026, 9:12 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $36.52
Real-time Price: $37.27 info
Change: +$0.7475 (+2%) info
Market Cap: $8.785B info
CTRE
Oct 02, 2026, 6:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $36.29
Real-time Price: $37.27 info
Change: +$0.9775 (+3%) info
Market Cap: $8.785B info
CTRE
Oct 02, 2026, 4:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $36.70
Real-time Price: $37.27 info
Change: +$0.5675 (+2%) info
Market Cap: $8.785B info